Partner Content

Partner Content
Kantar_ASCO Day 2 coverage pic 1
Partner Content

Positive PIII results for VYXEOS revealed at ASCO

Building on the announcement made in March of this year, Celator Pharmaceuticals has today (June 4th) presented the Phase III (PIII) findings for its combination therapy VYXEOS (cytarabine and daun

Partner Content
Kantar_ASCO Day 1 coverage pic
Partner Content

What are the key presentations at ASCO 2016?

The 2016 American Society of Clinical Oncology (ASCO) annual meeting starts today (3rd June), and it promises to be packed with the latest data and trends from the world of oncology.